951 related articles for article (PubMed ID: 17418683)
1. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
2. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).
Jacobsen PK
J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
6. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.
Fernandez-Juárez G; Barrio V; de Vinuesa SG; Goicoechea M; Praga M; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270
[TBL] [Abstract][Full Text] [Related]
7. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
Fronczyk A; Majkowska L
Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
[TBL] [Abstract][Full Text] [Related]
8. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
9. Role of angiotensin II in diabetic nephropathy.
Kennefick TM; Anderson S
Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
[TBL] [Abstract][Full Text] [Related]
10. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
Rossing P; Parving HH; de Zeeuw D
Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
[No Abstract] [Full Text] [Related]
11. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Wade VL; Gleason BL
Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
[TBL] [Abstract][Full Text] [Related]
12. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
13. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
Ritz E
MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
[No Abstract] [Full Text] [Related]
14. Treating diabetic nephropathy: unfinished success is not failure.
Lewis J
Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
[No Abstract] [Full Text] [Related]
15. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
Pisoni R; Faraone R; Ruggenent P; Remuzzi G
J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
Tocci G; Sciarretta S; Facciolo C; Volpe M
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654
[TBL] [Abstract][Full Text] [Related]
18. Are there effects of renin-angiotensin system antagonists beyond blood pressure control?
Bakris G
Am J Cardiol; 2010 Jan; 105(1 Suppl):21A-9A. PubMed ID: 20102970
[TBL] [Abstract][Full Text] [Related]
19. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
Barnas U; Mayer G
Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
Björck S; Aurell M
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]